NCT05690802View on ClinicalTrials.gov

The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV

NARecruitingINTERVENTIONAL
Enrollment

1,060

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

May 30, 2027

Study Completion Date

May 30, 2029

Conditions
Nausea and Vomiting
Interventions
DRUG

Palonosetron hydrochloride capsules

"This protocol only stipulates Palonosetron capsule containing hydrochloric acid protocol, and does not make uniform provisions on the treatment course, and does not interfere with the actual clinical usage and dosage."

Trial Locations (1)

710032

RECRUITING

The First Affiliated Hospital, the Air Force Medical University, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER